Angela Hagen

Title: Angela Hagen: Innovator in Pharmaceutical Chemistry

Introduction

Angela Hagen is a prominent inventor based in Berlin, Germany. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds with cardiotonic and vasodilatory properties. Her innovative work has led to the granting of a patent that showcases her expertise and dedication to advancing medical science.

Latest Patents

Angela Hagen holds a patent for a compound known as 3-cyano-5,4'-bipyridine-1'-oxide. This compound, along with its pharmaceutically acceptable acid addition salts, exhibits heart-stimulating properties. The patent details methods for preparing these compounds, which can be achieved by converting an R-substituted-3-cyano-bipyridine to its corresponding N-oxide or by substituting an R-residue. The versatility of these compounds makes them valuable in the pharmaceutical industry.

Career Highlights

Angela is currently employed at Arzneimittelwerk Dresden GmbH, where she continues to innovate and contribute to the development of new pharmaceutical products. Her work is characterized by a commitment to improving health outcomes through scientific research and development. With a patent portfolio that includes 1 patent, she has established herself as a key figure in her field.

Collaborations

Angela collaborates with esteemed colleagues such as Peter Muschick and Brigitte Schlegel. These partnerships enhance her research efforts and contribute to the success of her projects.

Conclusion

Angela Hagen is a dedicated inventor whose work in pharmaceutical chemistry has the potential to impact the medical field significantly. Her innovative compounds and collaborative spirit exemplify the essence of scientific advancement.